AstraZeneca filed a lawsuit seeking to block an Arkansas law that requires the company to ship its medicines to any pharmacy working with hospitals participating in a controversial federal discount program. The move comes less than a month after a U.S. appeals court upheld the same law, but the company is trying to make a different argument in hopes of stopping other states from pursuing similar laws.
The drugmaker maintained the Arkansas law improperly forces pharmaceutical companies to supply pharmacies — such as CVS and Walgreens — that technically are not covered by the discount program, known as 340B, according to the lawsuit filed in a federal court. As a result, AstraZeneca maintained the law is illegal because it is preempted by federal law and also violates the U.S. Constitution.
The lawsuit is the latest clash in a long-running battle over the 340B program, which was created to help hospitals and clinics care for low-income and rural patients. To ensure it achieves this goal, drugmakers that want to take part in Government-run Medicare or Medicaid must offer their medicines at a discount — typically, 25% to 50%, but sometimes higher — to participating hospitals and clinics.
Click this link for the original source of this article.
Author: Ed Silverman
This content is courtesy of, and owned and copyrighted by, https://www.statnews.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.